Roche announces FDA approves Susvimo to treat DME
Roche (RHHBY) announced that the Food and Drug Administration has approved Susvimo 100 mg/mL for the treatment of diabetic macular edema, a ...
Yahoo Finance9d
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Basel, 04 February 2025 - Roche (SIX: RO, ROG ... macular edema (DME), a leading cause of vision loss in adults with diabetes, affecting more than 29 million adults worldwide.
PharmiWeb9d
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. For over 125 years, ...
manilatimes9d
FDA approves Roche's Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
To provide the best care ... Roche Group. Genentech retains commercial rights in the United States and Novartis has exclusive commercial rights for the rest of the world. [1] Diep TM, et al. Risk ...
Yahoo Finance10d
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Basel, 04 February 2025 - Roche ... with diabetes, affecting more than 29 million adults worldwide. 1-3 Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with DME ...
News Medical on MSN2d
UVA launches trial to test AI-powered device for diabetes management
For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...
The New Zealand Herald29d
Sir Brian Roche spells out what’s wrong with the public service
Sir Brian Roche says there is a concern about the level of analysis given to Treaty "breaches". Photo / Marty Melville There are too many meetings in the public service, too many layers of ...